Reading an article by Ed Miseta, Clinical Leader, brought to mind the importance of the balance of patient’s needs and scientific advancement. Miseta’s article shared comments from leaders in Pharma where empowered patients and their community voice is recognized and discussed. Clinical trial design that includes patient input and discussions for “buy in” is a way to encourage participation in clinical trials and keep the enrollment going throughout. Patients are not only patients but people just trying to get through their days, working, family, friends and activities. Good to know that thought leaders are having these important discussions, like the one at the CROWN Congress, and implementing new ideas in clinical trials. Miseta’s article is a good read — I encourage you to look it over.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Pearl IRB 2024 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests
Common Rule Exceptions to the Use of a Single IRB for Multi-site Research Ends After May 11, 2023
Pearl IRB 2022 Year-End Schedule